Morgan E W, Yan B, Greenway D, Parkinson A
Department of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center, Kansas City 66160-7417.
Arch Biochem Biophys. 1994 Dec;315(2):513-26. doi: 10.1006/abbi.1994.1532.
The preceding paper described the purification of two rat liver microsomal carboxylesterases, designated hydrolases A and B, that have high affinity (Km approximately 25 microM) and low affinity (Km approximately 400 microM) for para-nitrophenylacetate, respectively. The present study describes the preparation and purification of polyclonal antibodies against these purified enzymes. Each antibody was subjected to immunoabsorption chromatography to remove antibodies against epitopes common to both hydrolases A and B. The resulting isozyme-specific antibodies were used to study the regulation of hydrolases A and B by Western immunoblotting and Ouchterlony immunodiffusion. Liver microsomes from mouse, hamster, rabbit, guinea pig, cat, dog, cynomolgus monkey, and humans contained one or more proteins that were immunochemically related and similar in size (M(r) approximately 60 kDa) to hydrolase A and/or hydrolase B. These proteins were preferentially recognized by the antibody against hydrolase A, except for cat liver microsomal esterase, which was preferentially recognized by antibody against hydrolase B. In rats, the levels of hydrolases A and B in liver microsomes were coregulated as a function of age, sex, and xenobiotic treatment of rats. The levels of both enzymes were very low in 1- and 2-week-old rats, but increased abruptly at 3 weeks of age in both male and female rats. Treatment of mature male rats with 11 known microsomal enzyme inducers caused little (< 35%) or no induction of hydrolase A or B, whereas treatment of rats with beta-naphthoflavone, pregnenolone- 16 alpha-carbonitrile or dexamethasone suppressed the levels of both enzymes. The kinetic analysis of para-nitrophenylacetate hydrolysis described in the preceding paper identified a high-affinity esterase (Km 20-35 microM) in rat liver, testis, lung, prostate, and pancreas and identified a low-affinity enzyme (Km 300-800 microM) in liver, kidney, small intestine, lung, brain, spleen, and heart. Immunoblot analysis established that hydrolase A was present in liver, testis, lung, and prostrate at concentrations that accounted for the high-affinity esterase activity in these tissues. Hydrolase A was not detected in the pancreas, even though this tissue contained low levels of a high-affinity esterase. Hydrolase B was detected in liver and kidney at concentrations that accounted for the low-affinity esterase activity in these tissues. Hydrolase B was not detected in the other tissues examined, some of which (e.g., small intestine) contained high levels of a low-affinity esterase. These results indicate that hydrolases A and B are independently expressed in a wide variety of extrahepatic tissues in rats.(ABSTRACT TRUNCATED AT 400 WORDS)
前文描述了两种大鼠肝脏微粒体羧酸酯酶的纯化过程,这两种酶分别命名为水解酶A和水解酶B,它们对乙酸对硝基苯酯的亲和力分别为高亲和力(Km约为25微摩尔)和低亲和力(Km约为400微摩尔)。本研究描述了针对这些纯化酶的多克隆抗体的制备和纯化。每种抗体都经过免疫吸附色谱法处理,以去除针对水解酶A和水解酶B共有的表位的抗体。所得的同工酶特异性抗体用于通过蛋白质免疫印迹法和双向免疫扩散法研究水解酶A和水解酶B的调节。来自小鼠、仓鼠、兔子、豚鼠、猫、狗、食蟹猴和人类的肝脏微粒体含有一种或多种在免疫化学上相关且大小(相对分子质量约为60 kDa)与水解酶A和/或水解酶B相似的蛋白质。除了猫肝脏微粒体酯酶优先被抗水解酶B的抗体识别外,这些蛋白质优先被抗水解酶A的抗体识别。在大鼠中,肝脏微粒体中水解酶A和水解酶B的水平随大鼠的年龄、性别和外源化合物处理而共同调节。在1周龄和2周龄的大鼠中,这两种酶的水平都非常低,但在3周龄时,雄性和雌性大鼠的这两种酶水平都突然升高。用11种已知的微粒体酶诱导剂处理成年雄性大鼠,对水解酶A或B几乎没有诱导作用(<35%)或没有诱导作用,而用β-萘黄酮、孕烯醇酮-16α-腈或地塞米松处理大鼠则会抑制这两种酶的水平。前文所述的乙酸对硝基苯酯水解的动力学分析确定,在大鼠肝脏、睾丸、肺、前列腺和胰腺中存在一种高亲和力酯酶(Km为20 - 35微摩尔),在肝脏、肾脏、小肠、肺、脑、脾脏和心脏中存在一种低亲和力酶(Km为300 - 800微摩尔)。蛋白质免疫印迹分析表明,水解酶A存在于肝脏、睾丸、肺和前列腺中,其浓度与这些组织中的高亲和力酯酶活性相当。尽管胰腺中含有低水平的高亲和力酯酶,但未检测到水解酶A。在肝脏和肾脏中检测到水解酶B,其浓度与这些组织中的低亲和力酯酶活性相当。在其他检测的组织中未检测到水解酶B,其中一些组织(如小肠)含有高水平的低亲和力酯酶。这些结果表明,水解酶A和水解酶B在大鼠的多种肝外组织中独立表达。(摘要截断于400字)